phospholipase/obesity

CROSS REFERENCE TO RELATED APPLICATIONS The present application is a national phase entry under 35 U.S.C. .sctn.371 of International Application No. PCT/JP2006/320611, filed Oct. 17, 2006, published in Japanese, which claims benefit of Japanese Patent Application No. 2005-321108, filed Nov. 4, 2005.

The present invention relates to azolopyridin-2-one derivatives of the general formula I, to their pharmaceutically useful salts and to their use as medicinal substances. Compounds of similar structure are known from EP 1275653. However, these are used as fungicides. Compounds having an inhibitory

FIELD OF INVENTION This invention relates to novel compositions of matter. More particularly, the invention relates to cyclic hydrocarbons with an aminoalkyl sidechain that are useful for inhibiting phospholipase A2 and for treating diabetes and obesity. INFORMATION DISCLOSURE The important role of

FIELD OF INVENTION This invention relates to novel compositions of matter. More particularly, the invention relates to cyclic hydrocarbons with an aminoalkyl sidechain that are useful for inhibiting phospholipase A2 and for treating diabetes and obesity. INFORMATION DISCLOSURE The important role of

FIELD OF INVENTION This invention relates to novel compositions of matter. More particularly, the invention relates to cyclic hydrocarbons with an aminoalkyl sidechain that are useful for inhibiting phospholipase A2 and for treating diabetes and obesity. INFORMATION DISCLOSURE The important role of

FIELD OF INVENTION This invention relates to novel compositions of matter. More particularly, the invention relates to cyclic hydrocarbons with an aminoalkyl sidechain that are useful for inhibiting phospholipase A2 and for treating diabetes and obesity. INFORMATION DISCLOSURE The important role of

FIELD OF INVENTION This invention relates to novel compositions of matter. More particularly, the invention relates to cyclic hydrocarbons with an aminoalkyl sidechain that are useful for inhibiting phospholipase A2. Information Disclosure The important role of phospholipase A2 in mammalian

FIELD OF INVENTION This invention relates to novel compositions of matter. More particularly, the invention relates to cyclic hydrocarbons with an aminoalkyl sidechain that are useful for inhibiting phospholipase A2 and for treating diabetes and obesity. INFORMATION DISCLOSURE The important role of

FIELD OF INVENTION This invention relates to novel compositions of matter. More particularly, the invention relates to cyclic hydrocarbons with an aminoalkyl sidechain that are useful for inhibiting phospholipase A2 and for treating diabetes and obesity. INFORMATION DISCLOSURE The important role of

FIELD OF INVENTION This invention encompasses novel cyclic hydrocarbons substituted with an aminoalkyl sidechain that are useful for inhibiting adverse physiological symptoms associated with phospholipase A2 and for treating hypoglycemia associated diseases such as diabetes and